Latent Variables-Based Process Modeling of a Continuous Hydrogenation Reaction in API Synthesis of Small Molecules

IntroductionContinuous manufacturing can be benefited by the use of the Quality by Design (QbD) strategy for robust process development and by the use of Process Analytical Technology (PAT) for real-time process monitoring and control. A successful implementation of QbD and PAT for continuous processes relies on a robust and information-rich process model as a basis for process understanding, monitoring, and control. Compared to first principles and other empirical models, a latent variables-based process model is capable of decomposing multidimensional process data into a few orthogonal latent variables and of providing accessible process understanding/visualization and control within the latent variable space. This study is an extension of our group’s earlier effort (Liu et al., J Pharm Innov 6:170–180, 2011) to explore the utility of latent variables-based process modeling in pharmaceutical manufacturing processes.MethodsThe case presented here is the first application of latent variables-based modeling to a reaction process in small-molecule active pharmaceutical ingredient route synthesis, i.e., a continuous-flow hydrogenation. A particular reactor configuration and operation was used in this proof-of-concept study.ResultsIt was found that time-variant profiles of pressure in the flow tube reactor served as an effective indicator of gas–liquid interaction within the reactor, thus determining process outcomes, i.e., the extent of reaction and enantiomeric excess (ee), given the importance of process set points. In addition, a design space of process parameters predicted to produce optimal outcomes, i.e., extent of reaction greater than 98 % and ee higher than 93 %, was established in order to provide a flexible operation space for performing the reaction with desired process outcomes.ConclusionsThe capabilities of latent variables-based process modeling have been well demonstrated as applied to a continuous-flow hydrogenation reaction, regarding its improved process understanding and the potential for process optimization & control as well. Future efforts will be focused on continuing understanding of the capabilities and limitations of such a methodology on a fully-automated control scheme for continuous flow reaction.

[1]  J. Westerhuis,et al.  Multivariate modelling of the pharmaceutical two‐step process of wet granulation and tableting with multiblock partial least squares , 1997 .

[2]  Don W. Green,et al.  Perry's Chemical Engineers' Handbook , 2007 .

[3]  Theodora Kourti,et al.  Process analysis, monitoring and diagnosis, using multivariate projection methods , 1995 .

[4]  John F. MacGregor,et al.  Modeling and Optimization of a Tablet Manufacturing Line , 2011, Journal of Pharmaceutical Innovation.

[5]  Roger Nosal,et al.  API Quality by Design Example from the Torcetrapib Manufacturing Process , 2007, Journal of Pharmaceutical Innovation.

[6]  Carlo Castagnoli,et al.  Application of Quality by Design Principles for the Definition of a Robust Crystallization Process for Casopitant Mesylate , 2010 .

[7]  J. Macgregor,et al.  Analysis of multiblock and hierarchical PCA and PLS models , 1998 .

[8]  Bernard McGarvey,et al.  The Use of Routine Process Capability for the Determination of Process Parameter Criticality in Small-molecule API Synthesis , 2008, Journal of Pharmaceutical Innovation.

[9]  Alan D. Braem,et al.  An Example of Utilizing Mechanistic and Empirical Modeling in Quality by Design , 2010, Journal of Pharmaceutical Innovation.

[10]  John F. MacGregor STATISTICAL PROCESS CONTROL OF MULTIVARIATE PROCESSES , 1994 .

[11]  J. Macgregor,et al.  A Framework for the Development of Design and Control Spaces , 2008, Journal of Pharmaceutical Innovation.

[12]  Salvador García Muñoz,et al.  Handling uncertainty in the establishment of a design space for the manufacture of a pharmaceutical product , 2010, Comput. Chem. Eng..

[13]  J. Macgregor,et al.  Experiences with industrial applications of projection methods for multivariate statistical process control , 1996 .

[14]  Alan D. Braem,et al.  Model-Guided Design Space Development for a Drug Substance Manufacturing Process , 2011, Journal of Pharmaceutical Innovation.

[15]  Koji Muteki,et al.  De-risking Pharmaceutical Tablet Manufacture Through Process Understanding, Latent Variable Modeling, and Optimization Technologies , 2011, AAPS PharmSciTech.

[16]  Don W. Green,et al.  Perry's chemical engineers' handbook. 7th ed. , 1997 .